Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: FCP
  • Objective: US
  • Asset Class: Equity
  • Geographic Focus: U.S.

Credit Suisse Lux USA Equity Fund

+ Add to Watchlist

CRSNADI:LX

2,564.92 USD 19.71 0.77%

As of 00:59:30 ET on 03/27/2015.

Snapshot for Credit Suisse Lux USA Equity Fund (CRSNADI)

Year To Date: +2.45% 3-Month: +1.85% 3-Year: +15.40% 52-Week Range: 2,136.71 - 2,617.97
1-Month: -1.31% 1-Year: +14.88% 5-Year: +12.83% Beta vs NDDLUS: 1.04

Mutual Fund Chart for CRSNADI

No chart data available.
  • CRSNADI:LX 2,564.92
  • 1M
  • 1Y
Interactive CRSNADI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for CRSNADI

Credit Suisse (Lux) USA Equity Fund is an open-end Fund incorporated in Luxembourg. The aim of the Fund is to achieve long-term capital appreciation by investing in a growth style biased portfolio of US companies. The Fund invests primarily in well-established medium to large-sized US companies that have the ability to deliver superior growth compared to their peers.

Inception Date: 12-13-2002 Telephone: 352-436-1611 Tel
Managers: MARCELLO MUSIO
Web Site: www.credit-suisse.com/lu

Fundamentals for CRSNADI

NAV (on 2015-03-27) 2,564.92
Assets (M) (on 2015-03-27) 435.33
Fund Leveraged N
Minimum Investment -
Minimum Subsequent Investment -

Dividends for CRSNADI

No dividends reported

Fees & Expenses for CRSNADI

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 0.00
Redemption Fee 0.00
12b1 Fee -
Expense Ratio 0.10

Top Fund Holdings for CRSNADI

Filing Date: 01/30/2015
Name Position Value % of Total
Apple Inc 209,931 24,595,516 4.919%
Gilead Sciences Inc 186,720 19,573,858 3.915%
CVS Health Corp 176,035 17,279,596 3.456%
Actavis plc 62,083 16,581,364 3.316%
Celgene Corp 138,954 16,557,759 3.312%
HCA Holdings Inc 191,062 13,527,190 2.705%
Skyworks Solutions Inc 121,585 10,097,634 2.020%
Thermo Fisher Scientific Inc 80,135 10,033,703 2.007%
Home Depot Inc/The 90,000 9,397,800 1.880%
Berkshire Hathaway Inc 65,000 9,354,150 1.871%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil